Active, not recruitingPhase 4NCT04314193
Effectiveness of Methotrexate Versus Prednisone as First-line Therapy for Pulmonary Sarcoidosis
Studying Sarcoidosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Erasmus Medical Center
- Principal Investigator
- Marlies Wijsenbeek, MD PhDErasmus Medical Center
- Intervention
- Methotrexate(drug)
- Enrollment
- 138 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2020 – 2026
Study locations (17)
- Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, Netherlands
- Vrije Universiteit Medisch Centrum, Amsterdam, Netherlands
- Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands
- Academisch Medisch Centrum, Amsterdam, Netherlands
- Rijnstate Ziekenhuis, Arnhem, Netherlands
- Amphia hospital, Breda, Netherlands
- Catharina Ziekenhuis, Eindhoven, Netherlands
- Medisch Spectrum Twente, Enschede, Netherlands
- Martini Ziekenhuis, Groningen, Netherlands
- Zuyderland Medisch Centrum, Heerlen, Netherlands
- Medical Center Leeuwarden, Leeuwarden, Netherlands
- Leids Universitair Medisch Centrum, Leiden, Netherlands
- Haaglanden Medisch Centrum, Leidschendam, Netherlands
- Sint Antonius Ziekenhuis, Nieuwegein, Netherlands
- Erasmus MC, Rotterdam, Netherlands
- +2 more locations on ClinicalTrials.gov
Collaborators
St. Antonius Hospital · Longfonds
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04314193 on ClinicalTrials.govOther trials for Sarcoidosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07498842Corticosteroid Tapering in SarcoidosisRoyal Brompton & Harefield NHS Foundation Trust
- RECRUITINGNANCT07073963Virtual Patient Groups for Sarcoidosis Associated FatigueThe Cleveland Clinic
- RECRUITINGPHASE2NCT07159074Repurposing Tilmanocept for Cardiac SarcoidosisDuke University
- RECRUITINGPHASE2NCT06978725A Phase 2 Study of the Safety and Efficacy of Brepocitinib in Adults With Cutaneous Sarcoidosis (BEACON)Priovant Therapeutics, Inc.
- RECRUITINGNANCT05954507Evaluation of the Prognostic Value of PET/MRI in Cardiac SarcoidosisAssistance Publique - Hôpitaux de Paris
- RECRUITINGPHASE2NCT06660732Rilonacept in Subjects With Cardiac SarcoidosisMayo Clinic
- RECRUITINGNANCT07384897Immune Cells Role in Lung Cancer and Their Use in Anticancer Immunotherapies and Inflammatory Lung DiseaseUniversité Catholique de Louvain
- RECRUITINGNCT06510894Diagnostic Utility of SGLT1/2 Inhibition to Facilitate Myocardial Glucose SuppressionUniversity of Pennsylvania